ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,983.25
-0.50%
US Tech 100
20,720.00
-0.36%
다우존스 지수
43,461.21
0.08%
Bitcoin
89,171.48
-2.49%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Capricor Therapeutics Inc (CAPR)

  7. Capricor Therapeutics Inc (CAPR) 뉴스

CAPR

Capricor Therapeutics (CAPR)

Capricor Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CAPR
일자시간출처헤드라인심볼기업
2025/02/1023:00GlobeNewswire Inc.Capricor Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CAPRCapricor Therapeutics Inc
2025/02/0607:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0709:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0304:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CAPRCapricor Therapeutics Inc
2025/01/0223:15GlobeNewswire Inc.Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular DystrophyNASDAQ:CAPRCapricor Therapeutics Inc
2024/12/1623:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2024/12/0510:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
2024/12/0306:15GlobeNewswire Inc.Capricor Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/2023:00GlobeNewswire Inc.Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines AgencyNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/1506:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CAPRCapricor Therapeutics Inc
2024/11/1406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/1406:01GlobeNewswire Inc.Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/1301:46Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/1223:00GlobeNewswire Inc.Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual MeetingNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/1214:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CAPRCapricor Therapeutics Inc
2024/11/0523:00GlobeNewswire Inc.Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13NASDAQ:CAPRCapricor Therapeutics Inc
2024/10/2503:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CAPRCapricor Therapeutics Inc
2024/10/2306:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CAPRCapricor Therapeutics Inc
2024/10/1905:01GlobeNewswire Inc.Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:CAPRCapricor Therapeutics Inc
2024/10/1805:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CAPRCapricor Therapeutics Inc
 검색 관련기사 보기:NASDAQ:CAPR

최근 히스토리

FX
USDEUR
US Dollar vs Euro
USOTC
RHHBY
Roche (QX)
NYSE
AXP
American Express
NYSE
CVX
Chevron
FX
USDJPY
US Dollar vs Yen
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
SPI
SP500
S&P 500
CCOM
US500
US 500
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
SILVER
SILVER
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지